Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Atypical pulmonary alveolar proteinosis presenting as a mixed nodular ground-glass opacity with focal mucinosis mimicking lung cancer.

Literature DB >> 30416819

Atypical pulmonary alveolar proteinosis presenting as a mixed nodular ground-glass opacity with focal mucinosis mimicking lung cancer.

Tsutomu Shinohara¹, Hiroyuki Hino², Shino Imanishi³, Keishi Naruse⁴, Yuji Ohtsuki⁵, Fumitaka Ogushi³.

Abstract

Entities: Disease

Year: 2018 PMID： 30416819 PMCID： PMC6196198 DOI： 10.21037/jtd.2018.08.77

Source DB: PubMed Journal: J Thorac Dis ISSN： 2072-1439 Impact factor: 2.895

Keyword Cloud
References

× No keyword cloud information.

22 in total

1. F-18 FDG PET/CT in pulmonary alveolar proteinosis.

Authors: Chun-Wei Hsu; Feng-Yuan Liu; Chih-Wei Wang; Horng-Chyuan Lin; Chien-Da Huang
Journal: Clin Nucl Med Date: 2009-02 Impact factor: 7.794

2. [A case of pulmonary alveolar proteinosis presenting with miniscule ground-glass opacity in the apex of the left lung].

Authors: Sayomi Matsushima; Koushi Yokomura; Takashi Matsui; Takafumi Suda; Kingo Chida
Journal: Nihon Kokyuki Gakkai Zasshi Date: 2011-07

3. Evaluation of Pulmonary Nodules: Clinical Practice Consensus Guidelines for Asia.

Authors: Chunxue Bai; Chang-Min Choi; Chung Ming Chu; Devanand Anantham; James Chung-Man Ho; Ali Zamir Khan; Jang-Ming Lee; Shi Yue Li; Sawang Saenghirunvattana; Anthony Yim
Journal: Chest Date: 2016-02-27 Impact factor: 9.410

4. Relationship of anti-GM-CSF antibody concentration, surfactant protein A and B levels, and serum LDH to pulmonary parameters and response to GM-CSF therapy in patients with idiopathic alveolar proteinosis.

Authors: J F Seymour; I R Doyle; K Nakata; J J Presneill; O D Schoch; E Hamano; K Uchida; R Fisher; A R Dunn
Journal: Thorax Date: 2003-03 Impact factor: 9.139

Review 5. Pulmonary alveolar proteinosis in adults: pathophysiology and clinical approach.

Authors: Anupam Kumar; Basem Abdelmalak; Yoshikazu Inoue; Daniel A Culver
Journal: Lancet Respir Med Date: 2018-02-01 Impact factor: 30.700

6. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan.

Authors: Yoshikazu Inoue; Bruce C Trapnell; Ryushi Tazawa; Toru Arai; Toshinori Takada; Nobuyuki Hizawa; Yasunori Kasahara; Koichiro Tatsumi; Masaaki Hojo; Toshio Ichiwata; Naohiko Tanaka; Etsuro Yamaguchi; Ryosuke Eda; Kazunori Oishi; Yoshiko Tsuchihashi; Chinatsu Kaneko; Toshihiro Nukiwa; Mitsunori Sakatani; Jeffrey P Krischer; Koh Nakata
Journal: Am J Respir Crit Care Med Date: 2008-01-17 Impact factor: 21.405

Atypical pulmonary alveolar proteinosis presenting as a mixed nodular ground-glass opacity with focal mucinosis mimicking lung cancer.

1. F-18 FDG PET/CT in pulmonary alveolar proteinosis.

2. [A case of pulmonary alveolar proteinosis presenting with miniscule ground-glass opacity in the apex of the left lung].

3. Evaluation of Pulmonary Nodules: Clinical Practice Consensus Guidelines for Asia.

4. Relationship of anti-GM-CSF antibody concentration, surfactant protein A and B levels, and serum LDH to pulmonary parameters and response to GM-CSF therapy in patients with idiopathic alveolar proteinosis.

Review 5. Pulmonary alveolar proteinosis in adults: pathophysiology and clinical approach.

6. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan.

7. [A case of idiopathic pulmonary alveolar proteinosis with multiple localized ground-glass opacities].

8. Surfactant proteins in pulmonary alveolar proteinosis in adults.

9. Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis.

10. Features of idiopathic pulmonary alveolar proteinosis in high resolution computed tomography.